NIPH Clinical Trials Search

JAPANESE
国立保健医療科学院
UMIN ID: UMIN000052876

Registered date:01/12/2023

Dual-center retrospective study on the efficacy and safety of neoadjuvant therapy in the patients with resectable pancreatic cancer

Basic Information

Recruitment status Recruiting
Health condition(s) or Problem(s) studiedpancreatic cancer
Date of first enrollment2023/10/16
Target sample size550
Countries of recruitmentJapan
Study typeObservational
Intervention(s)

Outcome(s)

Primary OutcomeComparison of overall survival between upfront surgery and neoadjuvant therapy in the patients with resectable pancreatic cancer
Secondary Outcome1. detection of prognostic factor in the patients with resectable pancreatic cancer 2. comparison of recurrence free survival between upfront surgery and neoadjuvant therapy 3. comparison of surgical outcome between upfront surgery and neoadjuvant therapy 4. comparison of morbidity and induction of the adjuvant therapy between upfront surgery and neoadjuvant therapy 5. detection of the unresectable factor in the patients received neoadjuvanvt therapy with resectable pancreatic cancer

Key inclusion & exclusion criteria

Age minimumNot applicable
Age maximumNot applicable
GenderMale and Female
Include criteria
Exclude criteria1. diagnosis of borderline or unresectable pancreatic cancer according to NCCN guideline (Ver.2. 2021) 2. conversion surgery in the patients with unresectable pancreatic cancer

Related Information

Contact

public contact
Name Atsushi Shimizu
Address 811-1, Kimiidera, Wakayama City, Wakayama, Japan Japan 641-8510
Telephone 073-441-0613
E-mail atsus28@wakayama-med.ac.jp
Affiliation School of Medicine, Wakayama Medical School Second Department of Surgery
scientific contact
Name Manabu Kawai
Address 811-1, Kimiidera, Wakayama City, Wakayama, Japan Japan
Telephone 073-441-0613
E-mail kawai@wakayama-med.ac.jp
Affiliation School of Medicine, Wakayama Medical School Second Department of Surgery